Key facts
- Eolas Medical’s last known valuation is $38.6M (Jan 2026).
- It has raised $19.9M; the latest was Later Stage VC ($12.0M) in Jan 2026.
- Notable investors include Innovate UK, Ascension, 7percent Ventures, Portfolio Ventures, Acton Capital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Eolas Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Eolas Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Eolas Medical
Developer a knowledge management platform designed to ensure equitable healthcare globally. The company's platform uses artificial intelligence and natural language processing to organize and harness knowledge to build a medical knowledge model, enabling hospitals to have a single source of truth for their medical knowledge to improve the efficiency of healthcare delivery and the overall quality of care for patients.
- Sector
- Healthcare
- HQ
- Belfast, United Kingdom
- Founded
- 2019
- Employees
- 19
- Website
- eolasmedical.com/
- Ownership
- Privately Held (backing)
Eolas Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Eolas Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Eolas Medical in its N-PORT filings yet. We sweep new filings monthly.